Characterization of cyclic AMP accumulation in cultured human corpus cavernosum smooth muscle cells

Journal of Urology

Volumn 152, Issue 4, 1994, Pages 1308-1314

  Palmer, L S ^a   Valcic, M ^a   Melman, A ^a   Giraldi, A ^a   Wagner, G ^a   Christ, G J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

cells, cultured; cyclic AMP; forskolin

Indexed keywords

CYCLIC AMP; FORSKOLIN; ISOPRENALINE; PROSTAGLANDIN E2;

ARTICLE; CORPUS CAVERNOSUM; DRUG MECHANISM; DRUG MIXTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MUSCLE CONTRACTION; MUSCLE RELAXATION; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

EID: 0028168492     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(17)32573-9     Document Type: Article

References (44)

1. + + level and contraction in vascular smooth muscle J. Pharmacol. Exp. Ther. 249 1989 895
2. J. Haynes Jr. J. Robinson L. Saunders A.E. Taylor S.J. Strada Role of cAMP-dependent protein kinase in cAMP-mediated vasodilation Am. J. Physiol. 262 1992 H511
3. 1 receptor-mediated human vascular smooth muscle relaxation J. Cardiovasc. Pharmacol. 19 1992 447
4. L. Barr Photomechanical coupling in the vertebrate sphincter pupillae CRC Crit. Rev. Clin. Neurobiol. 4 1989 325
5. J.C. Ruegg Vertebrate smooth muscle chapt. 9 J.C. Ruegg Calcium in Muscle Activation 1988 Springer-Verlag New York 230 235
6. K. Seamon J.W. Daly Activation of adenylate cyclase by the diterpine forskolin does not require the guanine nucleotide regulatory protein J. Biol. Chem. 256 1981 9799
7. H. Hedlund K.-E. Andersson Comparison of the responses to drugs acting on adrenoreceptors and muscarinic receptors in human isolated corpus cavernosum and cavernous artery J. Auton. Pharmacol. 5 1985 81
8. H. Hedlund K.-E. Andersson Contraction and relaxation induced by some prostanoids in isolated human penile erectile tissues and cavernous artery J. Urol. 134 1985 1245
9. H.J. Kirkeby K.-E. Andersson A. Forman Comparison of the effects of prostanoids on human penile circumflex veins and corpus cavernosum tissue Br. J. Urol. 72 1993 220
10. B. Davis-Joseph M. Valcic H. Taub W. Zhao M. Gondré A. Melman S.-F. Fan P.R. Brink G.J. Christ On the use of human control tissues for studying the physiology of erection and the etiology of erectile dysfunction J. Urol. 151 1994 432A
11. G.J. Christ M. Valcic S. Maayani A. Melman Kinetic studies of contraction in human erectile tissue (HET) and rabbit aortic rings in vitro: modulation by papaverine and the dihydropyridine analog nifedipine Int. J. Impot. Res. 1 1989 1
12. S.E. Lerner A. Melman G.J. Christ A review of erectile dysfunction: new insights and more questions J. Urol. 149 1993 1246
13. R. Virag D. Friedman M. Legman H. Virag Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure Angiology 35 1984 79
14. 1 J. Urol. 146 1991 786
15. R. Ottesen G. Wagner R. Virag J. Fahrenkrug Penile erections: possible role for vasoactive peptide as a neuropeptide Br. Med. J. 288 1984 9
16. J. Buvat A. Lemaire M. Buvat-Herbaut G. Marcolin Safety of intracavernous injections using an alpha-blocking agent J. Urol. 141 1989 1364
17. G.S. Brindley Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence Br. J. Psychiatry 143 1983 332
18. T.F. Lue E.A. Tanagho Physiology of erection and pharmacological management of impotence J. Urol. 137 1987 829
19. J.R. Jasper M.C. Michel P.A. Insel Molecular mechanisms of β-adrenergic receptor blockers with intrinsic sympathomimetic activity F.A.S.E.B. J. 2 1988 2891
20. 2+ in cultured human corporal smooth muscle cells Am. J. Physiol. 263 1992 C373
21. A.C. Campos de Cavalho C. Roy A.P. Moreno A. Melman E.L. Hertzberg G.J. Christ D.C. Spray Gap junctions formed of connexin-43 are found between smooth muscle cells of human corpus cavernosum J. Urol. 149 1993 1568
22. A.P. Moreno A.C. Campos de Cavalho G. Christ A. Melman D.C. Spray Gap junctional communication between human corpus cavernosum smooth muscle cells in culture: gating behavior and single channel events Am. J. Physiol. 264 1993 C80
23. G. Bhargava M. Valcic A. Melman Human corpora cavernosa smooth muscle cells in culture: influence of catecholamines and prostaglandins on cAMP formation Int. J. Impotence Res. 2 1990 35
24. A.G. Gilman A protein binding assay for adenosine 3′,5′-cyclic monophosphate Proc. Natl. Acad. Sci. 67 1970 305
25. O.H. Lowry N.J. Rosebrough A.L. Farr R.J. Randall Protein measurement with Folin phenol reagent J. Biol. Chem. 193 1951 265
26. G.J. Christ J. Goldfarb S. Maayani Receptor-mediated mutual-effect amplification elicited by phenylephrine and serotonin in isolated rabbit aorta J. Pharmacol. Exp. Ther. 252 1990 500
27. 2 receptors in isolated rat aorta J. Pharmacol. Exp. Ther. 256 1991 553
28. R.A.F. Dixon I.S. Sigal M.R. Candelore J.W. Regan M.G. Caron R.J. Lefkowitz Structural features required for ligand binding to the β -adrenergic receptor E.M.B.O. J. 6 1987 3269
29. B.K. Koblika T.S. Koblika K. Daniel R.B. Register W. Scattergood E. Rands C.D. Strader Chimeric α 2- and β 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity Science 240 1988 1310
30. C.D. Strader I.S. Sigal R.A.F. Dixon Genetic approaches to the determination of structure-function relationship to G protein-coupled receptors Trends Pharmacol. Sci. 26 Suppl. 1989
31. s-adenylate cyclase interactions F.A.S.E.B. J. 5 1991 2300
32. A. Laurenza E.M. Sutkowski K.B. Seamon Forskolin: a specific stimulator of adenylyl cyclase or a diterpine with multiple sites of action? Trends Pharmacol. Sci. 10 1989 442
33. A.R. Mokhtari L. Do Khac S. Harbon Forskolin alters sensitivity of the cAMP-generating system to stimulatory as well as to inhibitory agonists: a study with intact human platelets and guinea pig myometrium Eur. J. Biochem. 176 1988 131
34. J. Caprioli M. Sears Forskolin lowers intraocular pressure in rabbits, monkeys, and man Lancet 1 1983 958
35. W. Kramer J. Thormann M. Kindler M. Schlepper Effects of forskolin on left ventricular function in dilated cardiomyopathy Arzneimittelforschung 37 1987 364
36. G. Baumann S. Felix U. Sattelberger G. Klein Cardiovascular effects of forskolin (HL 362) in patients with idiopathic congestive cardiomyopathy-a comparative study with dobutamine and sodium nitroprusside J. Cardiovasc. Pharmacol. 16 1990 93
37. R. Bouhelal G. Guillon V. Homburger J. Bockaert For-skolin-induced change of the size of adenylate cyclase J. Biol. Chem. 260 1985 10901
38. 2 J. Biol. Chem. 261 1986 13469
39. J. Bokaert Coupling of receptors to G proteins, pharmacological implications Therapie 46 1991 413
40. J.W. Kebabian The cyclic AMP cascade: a signal transduction system Neurotransmissions 8 1992 1
41. A. Levitski From epinephrine to cyclic AMP Science 241 1988 800
42. D. Stickle R. Barber Analysis of receptor-mediated activation of GTP-binding protein/adenylate cyclase using the encounter coupling model Mol. Pharmacol. 43 1993 397
43. T.P. Kenakin P.H. Morgan Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists Mol. Pharmacol. 35 1989 214
44. G.J. Christ S. Maayani A. Melman Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in α-adrenoceptor responsiveness with age and disease in isolated tissues Br. J. Pharmacol. 101 1990 375